
Antiphospholipid syndrome (APS) is a disorder characterised by recurrent arterial or venous thrombosis and/or pregnancy losses, in the presence of persistently elevated levels of anticardiolipin antibodies and/or evidence of circulating lupus anticoagulant (these abnormalities are detected by blood tests). Primary APS occurs when there is no evidence of associated diseases. APS in the presence of an underlying disease, usually systemic lupus erythematosus, is called secondary APS.
Anticoagulants, Thrombosis, Antiphospholipid Syndrome, Prognosis, Diagnosis, Differential, Treatment Outcome, Antibodies, Anticardiolipin, Lupus Coagulation Inhibitor, Antibodies, Antiphospholipid, Humans, Fluorescein Angiography, Biomarkers
Anticoagulants, Thrombosis, Antiphospholipid Syndrome, Prognosis, Diagnosis, Differential, Treatment Outcome, Antibodies, Anticardiolipin, Lupus Coagulation Inhibitor, Antibodies, Antiphospholipid, Humans, Fluorescein Angiography, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
